Clinical Trial

KAN-004 for Immune-Related Diarrhea or Colitis

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to evaluate the safety and tolerability of KAN-004 in patients with immune-related colitis.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-19.
Status change: Not Yet Recruiting → Recruiting 2026-04-08
Trial Details
NCT Number NCT07196410
Lead Sponsor Centre hospitalier de l'Université de Montréal (CHUM)
Conditions Colitis, Diarrhea Caused by Antitumor Drugs
Enrollment 21 participants
Start Date 2026-03-01
Primary Completion 2028-12-31 (estimated)
Study Completion 2030-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-13